Clinical Development Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Clinical Development stocks.

Clinical Development Stocks Recent News

Date Stock Title
May 28 NBIX Neurocrine Biosciences CEO Gorman stepping down in October
May 28 NBIX Neurocrine Biosciences Announces CEO Succession Plan
May 28 ICLR Here's Why Investors Should Retain ICON (ICLR) Stock Now
May 28 NBIX Neurocrine Biosciences to Present New Phase 3 CAHtalyst™ Data in Adult and Pediatric Patients with CAH and Study Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH at ENDO 2024
May 28 TGTX TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting
May 27 CLDX Wall Street Analysts Think Celldex (CLDX) Could Surge 87.27%: Read This Before Placing a Bet
May 27 REGN The Biggest Biotechnology Company in Europe
May 26 REGN The Biggest Publicly Traded Biotech Company
May 25 REGN 2 Biotech Stocks to Buy in May
May 24 REGN After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February
May 24 ICLR Icon PLC (ICLR) Up 6.6% Since Last Earnings Report: Can It Continue?
May 24 REGN Ireland – the jewel in the life sciences crown?
May 24 REGN Regeneron (REGN) Announces Positive Data on Oncology Candidate
May 23 REGN Promising Anti-tumor Activity of Novel Costimulatory Bispecific Antibody REGN7075 (EGFRxCD28) in Combination with Libtayo® (cemiplimab) to be Reported at ASCO
May 23 GMED Globus Medical (GMED) Hits 52-Week High: What's Driving It?
May 23 REGN 3 Stocks That Have Turned $25,000 Into More Than $1 Million in 15 Years
May 22 REGN Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Trading At A 48% Discount?
May 22 REGN Regeneron faces new biosimilar threats; an AI biotech lays off staff
Clinical Development

Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.

Browse All Tags